Ence Chuck
CAO and COO
Ence Chuck has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Nov 6, 2025.
On the most recent filing, Ence Chuck is listed as CAO and COO at RELMADA THERAPEUTICS, INC. Inside the rolling window, Ence Chuck reported 1 open-market purchase totaling $299K in RLMD and no open-market sales.
Companies traded
Other insiders at RLMD
Insider Buying
$299K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ence Chuck made?
Ence Chuck has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2025.
Which companies does Ence Chuck trade?
Ence Chuck has filed SEC Form 4 disclosures for 1 company, including RLMD.
When was Ence Chuck's most recent SEC Form 4 filing?
Ence Chuck's most recent SEC Form 4 filing on Tracefour is dated Nov 6, 2025.
What is Ence Chuck's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ence Chuck is listed as CAO and COO.
What is Ence Chuck's total buy and sell value in the current window?
Inside the rolling retention window, Ence Chuck bought $299K and sold $0 based on SEC Form 4 filings.
What was Ence Chuck's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 136,000 RLMD shares on 2025-11-05, worth $299K, per SEC Form 4 filings.